<VariationArchive VariationID="2749986" VariationName="NM_022552.5(DNMT3A):c.1151del (p.Phe384fs)" VariationType="Deletion" Accession="VCV002749986" Version="1" RecordType="classified" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2024-02-20" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2918944" VariationID="2749986">
      <GeneList>
        <Gene Symbol="DNMT3A" FullName="DNA methyltransferase 3 alpha" GeneID="1788" HGNC_ID="HGNC:2978" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>2p23.3</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25227874" stop="25342590" display_start="25227874" display_stop="25342590" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="25455829" stop="25565458" display_start="25455829" display_stop="25565458" Strand="-" />
          </Location>
          <OMIM>602769</OMIM>
          <Haploinsufficiency last_evaluated="2018-04-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DNMT3A">Little evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2018-04-29" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=DNMT3A">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_022552.5(DNMT3A):c.1151del (p.Phe384fs)</Name>
      <CanonicalSPDI>NC_000002.12:25246747:AA:A</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>2p23.3</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="2" Accession="NC_000002.12" start="25246748" stop="25246748" display_start="25246748" display_stop="25246748" variantLength="1" positionVCF="25246747" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="2" Accession="NC_000002.11" start="25469617" stop="25469617" display_start="25469617" display_stop="25469617" variantLength="1" positionVCF="25469616" referenceAlleleVCF="GA" alternateAlleleVCF="G" />
      </Location>
      <ProteinChange>F161fs</ProteinChange>
      <ProteinChange>F195fs</ProteinChange>
      <ProteinChange>F232fs</ProteinChange>
      <ProteinChange>F384fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_459" sequenceAccession="LRG_459">
            <Expression>LRG_459:g.100843del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_459t1" sequenceAccession="LRG_459t1">
            <Expression>LRG_459t1:c.1150del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_459p1" sequenceAccession="LRG_459p1" change="p.Phe384Serfs">
            <Expression>LRG_459p1:p.Phe384Serfs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_459t2" sequenceAccession="LRG_459t2">
            <Expression>LRG_459t2:c.584del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_459p2" sequenceAccession="LRG_459p2" change="p.Phe195fs">
            <Expression>LRG_459p2:p.Phe195fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_459t4" sequenceAccession="LRG_459t4">
            <Expression>LRG_459t4:c.1151del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_459p4" sequenceAccession="LRG_459p4" change="p.Phe384fs">
            <Expression>LRG_459p4:p.Phe384fs</Expression>
          </ProteinExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.11" sequenceAccession="NC_000002" sequenceVersion="11" change="g.25469618del" Assembly="GRCh37">
            <Expression>NC_000002.11:g.25469618del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000002.12" sequenceAccession="NC_000002" sequenceVersion="12" change="g.25246749del" Assembly="GRCh38">
            <Expression>NC_000002.12:g.25246749del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_029465.2" sequenceAccession="NG_029465" sequenceVersion="2" change="g.100843del">
            <Expression>NG_029465.2:g.100843del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_094703.1" sequenceAccession="NG_094703" sequenceVersion="1" change="g.283del">
            <Expression>NG_094703.1:g.283del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001320893.1" sequenceAccession="NM_001320893" sequenceVersion="1" change="c.695del">
            <Expression>NM_001320893.1:c.695del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001307822.1" sequenceAccession="NP_001307822" sequenceVersion="1" change="p.Phe232fs">
            <Expression>NP_001307822.1:p.Phe232fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001375819.1" sequenceAccession="NM_001375819" sequenceVersion="1" change="c.482del">
            <Expression>NM_001375819.1:c.482del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001362748.1" sequenceAccession="NP_001362748" sequenceVersion="1" change="p.Phe161fs">
            <Expression>NP_001362748.1:p.Phe161fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_022552.5" sequenceAccession="NM_022552" sequenceVersion="5" change="c.1151del" MANESelect="true">
            <Expression>NM_022552.5:c.1151del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_072046.2" sequenceAccession="NP_072046" sequenceVersion="2" change="p.Phe384fs">
            <Expression>NP_072046.2:p.Phe384fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_153759.3" sequenceAccession="NM_153759" sequenceVersion="3" change="c.584del">
            <Expression>NM_153759.3:c.584del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_715640.2" sequenceAccession="NP_715640" sequenceVersion="2" change="p.Phe195fs">
            <Expression>NP_715640.2:p.Phe195fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_175629.2" sequenceAccession="NM_175629" sequenceVersion="2" change="c.1151del">
            <Expression>NM_175629.2:c.1151del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_783328.1" sequenceAccession="NP_783328" sequenceVersion="1" change="p.Phe384fs">
            <Expression>NP_783328.1:p.Phe384fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="non-coding">
          <NucleotideExpression sequenceAccessionVersion="NR_135490.2" sequenceAccession="NR_135490" sequenceVersion="2" change="n.1382del">
            <Expression>NR_135490.2:n.1382del</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001619" Type="non-coding transcript variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_022552.5(DNMT3A):c.1151del (p.Phe384fs) AND Tatton-Brown-Rahman overgrowth syndrome" Accession="RCV003584227" Version="1">
        <ClassifiedConditionList TraitSetID="16415">
          <ClassifiedCondition DB="MedGen" ID="C4014545">Tatton-Brown-Rahman overgrowth syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-08-04" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-08-04" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2024-02-14" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">24614070</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="16415" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="21246" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Tatton-Brown-rahman syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Tall stature-intellectual disability-facial dysmorphism syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Tatton-Brown-Rahman overgrowth syndrome</ElementValue>
                <XRef ID="MONDO:0014382" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Alternate">TBRS</ElementValue>
                <XRef Type="MIM" ID="615879" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">Tatton-Brown-Rahman syndrome (TBRS) is an overgrowth / intellectual disability syndrome characterized by length/height and/or head circumference =2 SD above the mean for age and sex, obesity / increased weight, intellectual disability that ranges from mild to severe, joint hypermobility, hypotonia, behavioral/psychiatric issues, kyphoscoliosis, and seizures. Individuals with TBRS have subtle dysmorphic features, including a round face with coarse features, thick horizontal low-set eyebrows, narrow (as measured vertically) palpebral fissures, and prominent upper central incisors. The facial gestalt is most easily recognizable in the teenage years. TBRS may be associated with an increased risk of developing acute myeloid leukemia. There are less clear associations with aortic root dilatation and increased risk of other hematologic and solid tumors.</Attribute>
                <XRef ID="NBK581652" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="17674" />
                <XRef ID="17674" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">35771960</ID>
                <ID Source="BookShelf">NBK581652</ID>
              </Citation>
              <XRef ID="404443" DB="Orphanet" />
              <XRef ID="C4014545" DB="MedGen" />
              <XRef ID="MONDO:0014382" DB="MONDO" />
              <XRef Type="MIM" ID="615879" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7998786" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2024-02-14">
        <ClinVarSubmissionID localKey="26319132|MedGen:C4014545" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004311305" DateUpdated="2024-02-14" DateCreated="2024-02-14" Type="SCV" Version="1" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-08-04">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">24614070</ID>
          </Citation>
          <Comment>For these reasons, this variant has been classified as Pathogenic. This variant has not been reported in the literature in individuals affected with DNMT3A-related conditions. This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Phe384Serfs*23) in the DNMT3A gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in DNMT3A are known to be pathogenic (PMID: 24614070).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="DNMT3A" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000002.11:g.25469617del</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C4014545" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB14200283</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7998786" TraitType="Disease" MappingType="XRef" MappingValue="C4014545" MappingRef="MedGen">
        <MedGen CUI="C4014545" Name="Tatton-Brown-Rahman overgrowth syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

